Table 1 Baseline characteristics of study sample, overall and by group assignment
From: An acceptability and safety study of the Duet® cervical barrier and gel delivery system in Zimbabwe
Characteristic | Total (n = 103) | Continuous→precoital (n = 42) | Precoital→continuous (n = 41) | Observation (n = 20) | ||||
|---|---|---|---|---|---|---|---|---|
mean | median | mean | median | mean | median | mean | median | |
Age | 30.2 | 30.0 | 29.7 | 29.0 | 30.8 | 30.0 | 29.9 | 31.0 |
No. partners, past 3 mos. | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
n | % | n | % | n | % | n | % | |
Ethnicity | ||||||||
Shona | 67 | 65.7 | 28 | 66.7 | 27 | 65.9 | 12 | 63.2 |
Other | 35 | 34.3 | 14 | 33.3 | 14 | 34.2 | 7 | 36.8 |
Relationship status | ||||||||
Married | 102 | 100.0 | 42 | 100.0 | 41 | 100.0 | 19 | 100.0 |
Parity | ||||||||
1-2 | 39 | 38.2 | 22 | 52.4 | 13 | 31.7 | 4 | 21.0 |
3 or more | 63 | 61.7 | 20 | 47.6 | 28 | 68.3 | 15 | 78.9 |
Current contraception | ||||||||
Long-term contraceptives | 5 | 4.9 | 1 | 2.4 | 3 | 7.3 | 1 | 5.3 |
Injectables | 29 | 28.4 | 12 | 28.6 | 14 | 34.2 | 3 | 15.8 |
Oral contraceptives | 68 | 66.7 | 29 | 69.1 | 24 | 58.5 | 15 | 79.0 |
Ever treated for RTI/STI, lifetime | ||||||||
Yes | 15 | 14.7 | 8 | 19.1 | 5 | 12.2 | 2 | 10.5 |
Any symptoms, past 3 mos. | ||||||||
Yes | 14 | 13.7 | 6 | 14.3 | 6 | 14.6 | 2 | 10.5 |
BV status at baseline | ||||||||
Positive | 19 | 19.2 | 12 | 28.6 | 4 | 10.8 | 3 | 15.0 |
Ever used male condoms | ||||||||
Yes | 83 | 80.6 | 32 | 76.2 | 32 | 78.1 | 19 | 95.0 |
Male condom use, past 3 mos. | ||||||||
All of the time | 8 | 9.5 | 1 | 3.0 | 4 | 12.5 | 3 | 15.8 |
Sometimes | 35 | 41.7 | 16 | 48.5 | 9 | 28.1 | 10 | 52.6 |
Never | 41 | 48.8 | 16 | 48.5 | 19 | 59.4 | 6 | 31.6 |
Ever used diaphragm, past 3 mos. | ||||||||
Yes | 12 | 11.7 | 4 | 9.5 | 5 | 12.2 | 3 | 15.0 |